Etodolac and Prochlorperazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Prochlorperazine (prochlorperazine). Common drug interactions include arthralgia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Prochlorperazine. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Prochlorperazine?

Prochlorperazine has active ingredients of prochlorperazine. It is often used in nausea. eHealthMe is studying from 14,632 Prochlorperazine users. Check the latest studies of Prochlorperazine.



On Jul, 09, 2026

71 people who take Etodolac and Prochlorperazine together, and have interactions are studied.

Etodolac and Prochlorperazine drug interactions.

What are the common drug interactions of Etodolac and Prochlorperazine, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Bone disorder
  4. Cellulitis (infection under the skin)
  5. Cystocele (a condition that occurs when the tough fibrous wall between a woman's bladder and her vagina is torn by childbirth)
  6. Eating disorder
  7. Emotional distress
  8. Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury)
  9. Exostosis (formation of new bone on the surface of a bone)
  10. Face injury

male:

  1. Anaemia (lack of blood)
  2. Fall
  3. Muscular weakness (muscle weakness)
  4. Neoplasm progression (growth of tumour)
  5. Plasma cell myeloma (cancer that begins in plasma cells)
  6. Arthralgia (joint pain)
  7. Confusional state
  8. Tooth infection
  9. Angina pectoris (chest pain due to ischemia of the heart muscle)
  10. Asthma

What are the common drug interactions of Etodolac and Prochlorperazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Jugular vein thrombosis (clot in jugular vein)
  2. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Blood chloride decreased
  3. Blood potassium increased
  4. Blood sodium decreased
  5. Blood urea increased
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Gallbladder disorder
  8. Multiple myeloma (cancer of the plasma cells)
  9. Pancreatitis (inflammation of pancreas)
  10. Platelet count decreased

50-59:

  1. Rectal fissure (painful condition in which a cut or tear occurs in the anus)
  2. Rectal haemorrhage (bleeding from anus)
  3. Rectocele (a bulging of the front wall of the rectum into the back wall of the vagina)
  4. Scar
  5. Seborrhoeic keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest)
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Staphylococcal infection (an infection with staphylococcus bacteria)
  8. Tooth loss
  9. Toothache (tooth pain)
  10. Urinary incontinence (inability to control the flow of urine and involuntary urination)

60+:

  1. Anaemia (lack of blood)
  2. Death
  3. Haemoglobin decreased
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Myalgia (muscle pain)
  6. Neoplasm malignant (cancer tumour)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Pneumonia fungal
  10. Renal failure acute (rapid kidney dysfunction)

What are the existing conditions these people have? *

  1. Hypercalcaemia (elevated calcium (ca+) level in the blood): 15 people, 21.13%
  2. Breast Cancer: 15 people, 21.13%
  3. Breast Cancer Metastatic: 14 people, 19.72%
  4. Cancer Pain: 9 people, 12.68%
  5. Multiple Myeloma (cancer of the plasma cells): 7 people, 9.86%
  6. Pain: 6 people, 8.45%
  7. Insomnia (sleeplessness): 6 people, 8.45%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 8.45%
  9. Stress And Anxiety: 5 people, 7.04%
  10. High Blood Pressure: 5 people, 7.04%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Prochlorperazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Etodolac and Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etodolac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Etodolac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prochlorperazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on etodolac and prochlorperazine (the active ingredients of Etodolac and Prochlorperazine, respectively), and Etodolac and Prochlorperazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: